Navigation Links
Cystic Fibrosis Foundation Lauds Congress for Passage of Small Business Innovation Research Program
Date:4/24/2008

Revised Law Includes Designated Funding for Rare Diseases

BETHESDA, Md., April 24 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation today lauded the U.S. House of Representatives for passing legislation to reauthorize the Small Business Innovation Research (SBIR) program.

In response to testimony from Robert J. Beall, Ph.D., president and CEO of the Foundation, the legislation includes a provision requiring that special attention be given to research for rare diseases, such as cystic fibrosis, when SBIR grants are awarded.

The SBIR program provides grants to small biotechnology and pharmaceutical companies for research and development programs focused on innovative treatments for rare diseases.

"We congratulate members of the House for recognizing the importance of funding for rare disease research and how critical these dollars are for cystic fibrosis and other devastating illnesses," said Beall. "The SBIR grants have been an important catalyst for several of our biotech collaborators working to find a cure. This special focus for the program is a win-win for everyone."

The Cystic Fibrosis Foundation was one of 20 organizations that supported the inclusion of rare disease research as an area of research that is "deserving of special attention in the SBIR program's reauthorization legislation." House Small Business Committee Chairwoman Nydia Velazquez (D-NY) and Ranking Republican Steve Chabot (R-OH) played a key role in the inclusion of this rare disease focus.

The legislation now moves to the U.S. Senate for consideration.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation has more than 80 chapters and branch offices throughout the country and supports and accredits a nationwide network of more than 115 care centers.
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
2. Anaheim to Host Worlds Largest Cystic Fibrosis Medical Meeting
3. AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration
4. Cystic Fibrosis Foundation Named Charitable Organization of the Year by USA Track & Field
5. Cystic Fibrosis foundation lays out new treatment guidelines
6. Experts Release New Cystic Fibrosis Guidelines
7. Lung Transplants May Not Help Most Cystic Fibrosis Children
8. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
9. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
10. Montana Passes Newborn Screening Law for Cystic Fibrosis
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
... child spikes a high fever, sometimes as high as 1... Shes rushed to the emergency room, the hospital r...ut no explanation is found. , Many families thou...nt respond to antibiotics or fever reducers like M...
...Magazine urges readers to participate in nationwid...IA, March 28 Smart Genetics has,announced that PA...art of a,nationwide poll asking readers if they wa...lligenc ,e_Report#health., PARADE, the nation,s m...
...ease in specific white blood cells could warn doct... March 28 (HealthDay News) -- Researchers at Templ...ker that denotes the progression of the virus that...s (HIV), according to a study published in the Mar...
...ASHINGTON, March 28 Richard T. Clark, Chief,Execu...oard chairman of the,Pharmaceutical Research and M... association,s annual meeting. Also elected were A...frey B.,Kindler as board treasurer., In addition,...
...lunt cerebrovascular injuries can be diagnosed usi...no need for an additional neck MDCT angiography ex... researchers at the University of Maryland Medical...In the past, blunt trauma patients would undergo w...
...hiladelphia, March 28, 2008 Many parents are conv...re different than those of children and adults. Ne...by Jay N. Giedd, MD, of the National Institute of ... cognition, emotion and behavior. , Dr. Giedd rev...
Other Medicine News:Health News:Mysterious fevers of unknown origin: Could surgery be a cure? 2Health News:PARADE Magazine Features Smart Genetics and Alzheimer's Mirror 2Health News:Biomarker May Signal HIV Progression 2Health News:Richard T. Clark Elected PhRMA Board Chairman 2Health News:Richard T. Clark Elected PhRMA Board Chairman 3Health News:Richard T. Clark Elected PhRMA Board Chairman 4Health News:Richard T. Clark Elected PhRMA Board Chairman 5Health News:Whole body MDCT just as 'good' as neck MDCT angiography in diagnosing head and neck injuries 2Health News:Are teenage brains really different? 2Health News:Are teenage brains really different? 3
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 1CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 3CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 4CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 5Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 1Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 2Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 3Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 4AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 1AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 2
Flammable Chemical Storage Cabinets
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q64-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q43-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q72-R-PAL
Medicine Products: